Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Fusidic Acid (compound)


PubChem
Name: Fusidic Acid
PubChem Compound ID: 11466473
Description: An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis.
Molecular formula: C31H48O6
Molecular weight: 516.709 g/mol
DrugBank
Identification
Name: Fusidic Acid
Name (isomeric): DB02703
Drug Type: small molecule
Description: An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis.
Synonyms:
Fucidic acid; Fucidate; Fusidate Sodium; Fucidate Sodium; Diethanolamine fusidate; Fusidate
Brand: Ramycin, Fucidin acid, Fucidin, Fucidin Cream 2%, Fucithalmic, Fusidine, Fucidine
Brand name mixture: Fucibet(Fusidic acid + betamethasone), Fucicort(Fusidic acid + hydrocortisone)
Category: Protein Synthesis Inhibitors, Anti-Bacterial Agents, Antibacterial Agents
CAS number: 6990-06-3
Pharmacology
Indication: For the treatment of bacterial infections.
Pharmacology: Fusidic acid is a bacteriostatic antibiotic that is often used topically in creams and eyedrops, but may also be given systemically as tablets or injections.
Mechanism of Action: Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.
Absorption: Sodium fusidic acid tablets have a 91% oral bioavailability. Absorption of the film-coated tablets is complete when compared to a solution, however oral absorption is variable. Oral fusidic acid hemihydrate (suspension) achieved a 22.5% bioavailability in pediatric patients following a 20 milligram/kilogram dose.
Protein binding: 97 to 99%
Biotransformation: Metabolites include dicarboxylic ester/acid, 3-keto fusidic acid, hydroxy fusidic acid, glucuronide fusidic acid and a glycol metabolite.
Half Life: Approximately 5 to 6 hours in adults.
Affected organisms: Enteric bacteria and other eubacteria
Interactions
Food interaction:
Take with food to reduce irritation.
Drug interaction:
FosamprenavirThe protease inhibitor, fosamprenavir, may increase the effect and toxicity of fusidic acid.
TipranavirConcomitant therapy of Tipranavir with Fusidic acid may result in increased serum concentrations of both agents. Consider alternate therapy or monitor for increased serum concentrations and toxocity of both agents.
Penicillin VFusidic acid may diminish the therapeutic effect of penicillins. To management this interaction, penicillin should be administered 2 hours before fusidic acid.
IndinavirIndinavir may increase the effect and toxicity of fusidic acid.
SaquinavirThe protease inhibitor, saquinavir, may increase the effect and toxicity of fusidic acid.
show more »

Targets


Transporters